Document is current
Any future updates will be listed below
-
Authors
Sowah, Solomon A.
Milanese, Alessio
Schübel, Ruth
Wirbel, Jakob
Kartal, Ece
Johnson, Theron S.
Hirche, Frank
Grafetstätter, Mirja
Nonnenmacher, Tobias
Kirsten, Romy
López-Nogueroles, Marina
Lahoz, Agustín
Schwarz, Kathrin V.
Okun, Jürgen G.
Ulrich, Cornelia M.
Nattenmüller, Johanna
von Eckardstein, Arnold
Müller, Daniel
Stangl, Gabriele I.
Kaaks, Rudolf
Kühn, Tilman
Zeller, Georg https://orcid.org/0000-0003-1429-7485
-
Funding
Funding for this research was provided by:
Helmholtz-Gemeinschaft
Stiftung zur Förderung der Erforschung der Zivilisationserkrankungen
Huntsman Cancer Foundation
National Institutes of Health (U01 CA 206110)
Deutscher Akademischer Austauschdienst
Bundesministerium für Bildung und Forschung (031L0181A)
European Molecular Biology Laboratory (EMBL)
- License Information
-
More Information
Article History
Received: 1 March 2021
Accepted: 14 February 2022
First Online: 14 March 2022
Declarations
:
: The ethics committee of the Heidelberg University Hospital (Heidelberg, Germany , Reference: vote S299-2014) and the EMBL Bioethics Advisory Committee approved the trial (Reference: 2020-022), which was designed and conducted in agreement with the principles of the World Medical Association’s Declaration of Helsinki. All participants signed informed consent forms before enrolment.
: Not applicable.
: The authors declare that they have no competing interests.
